ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,618Medicare Part D Prescriptions Filled, Including Refills
$245K Total Retail Price of All Prescriptions
348 Patients Receiving at Least One Drug in Part D
37%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
AMLODIPINE BESYLATE 384 127
LISINOPRIL 299 123
SIMVASTATIN 273 116
TRAMADOL HCL 239 69
METFORMIN HCL 231 81
HYDROCHLOROTHIAZIDE 221 68
OXYCODONE-ACETAMINOPHEN 202 43 S2
HYDROCODONE-ACETAMINOPHEN 198 41 S3
CLONIDINE HCL 198 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 158 63
PROMETHAZINE HCL 156 0 R
ZOLPIDEM TARTRATE 145 48
FUROSEMIDE 132 57
CYCLOBENZAPRINE HCL 131 32 R
GLIPIZIDE 124 39
OMEPRAZOLE 116 47
ATENOLOL 108 43
IBUPROFEN 108 33
ACETAMINOPHEN-CODEINE 94 36 S3
GABAPENTIN 91 19
PROAIR HFA 89 21
CIPROFLOXACIN HCL 86 20
KLOR-CON M20 75 35
VENTOLIN HFA 75 19
ATORVASTATIN CALCIUM 73 47
AMOXICILLIN 70 16
ADVAIR DISKUS 68 0
BUTALB-CAFF-ACETAMINOPH-CODEIN 66 0 S3 R 10
LANTUS SOLOSTAR 57 18
LOSARTAN POTASSIUM 56 29
METOPROLOL TARTRATE 55 39
CLOPIDOGREL 51 39
METOPROLOL SUCCINATE 50 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 2, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.